244 related articles for article (PubMed ID: 28552534)
41. Mutation analysis of tumor necrosis factor alpha-induced protein 3 gene in Hodgkin lymphoma.
Etzel BM; Gerth M; Chen Y; Wünsche E; Facklam T; Beck JF; Guntinas-Lichius O; Petersen I
Pathol Res Pract; 2017 Mar; 213(3):256-260. PubMed ID: 28189285
[TBL] [Abstract][Full Text] [Related]
42. Hodgkin lymphoma with unusual intrasinusoidal pattern of infiltration.
Lee SS; Ryoo BY; Park YH; Park S; Kim MS; Park KH; Kim CW
Leuk Lymphoma; 2004 Oct; 45(10):2135-41. PubMed ID: 15370261
[TBL] [Abstract][Full Text] [Related]
43. Classical Hodgkin Lymphoma with Positive Epstein-Barr Virus Status is Associated with More FOXP3 Regulatory T Cells.
Pavlovic A; Glavina Durdov M; Capkun V; Jakelic Pitesa J; Bozic Sakic M
Med Sci Monit; 2016 Jul; 22():2340-6. PubMed ID: 27377121
[TBL] [Abstract][Full Text] [Related]
44. Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma.
Tiacci E; Döring C; Brune V; van Noesel CJ; Klapper W; Mechtersheimer G; Falini B; Küppers R; Hansmann ML
Blood; 2012 Nov; 120(23):4609-20. PubMed ID: 22955914
[TBL] [Abstract][Full Text] [Related]
45. Lymph node infarction in classical Hodgkin's lymphoma.
Mori E; Enomoto Y; Nakamine H; Kasai T; Takeda M; Takano M; Morita K; Koizumi T; Nonomura A
J Clin Exp Hematop; 2012; 52(1):35-9. PubMed ID: 22706529
[TBL] [Abstract][Full Text] [Related]
46. Use of an expanded immunohistochemical panel to distinguish cutaneous Hodgkin lymphoma from histopathologic imitators.
Cho RJ; McCalmont TH; Ai WZ; Fox LP; Treseler P; Pincus LB
J Cutan Pathol; 2012 Jun; 39(6):651-8. PubMed ID: 22324490
[TBL] [Abstract][Full Text] [Related]
47. 3D connectomes of reactive and neoplastic CD30 positive lymphoid cells and surrounding cell types.
Lumer L; Wurzel P; Scharf S; Schäfer H; Ackermann J; Koch I; Hansmann ML
Acta Histochem; 2021 Jul; 123(5):151750. PubMed ID: 34233254
[TBL] [Abstract][Full Text] [Related]
48. Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a clinicopathological study of 14 Epstein-Barr virus-positive cases.
Elsayed AA; Satou A; Eladl AE; Kato S; Nakamura S; Asano N
Histopathology; 2017 Mar; 70(4):579-594. PubMed ID: 27735994
[TBL] [Abstract][Full Text] [Related]
49. Epstein-Barr virus-related Hodgkin's disease showing B cell lineage in an immunosuppressive patient seropositive for HTLV-I.
Murata T; Nakamura S; Kato H; Yatabe Y; Shiraishi T; Kuroda M; Yatani R; Suchi T
Pathol Int; 1997 Nov; 47(11):801-5. PubMed ID: 9413042
[TBL] [Abstract][Full Text] [Related]
50. Anaplastic variant of diffuse large B-cell lymphoma: Reappraisal as a nodal disease with sinusoidal involvement.
Megahed NA; Kohno K; Sakakibara A; Eladl AE; Elsayed AA; Wu CC; Suzuki Y; Takahara T; Kato S; Nakamura S; Satou A; Asano N
Pathol Int; 2019 Dec; 69(12):697-705. PubMed ID: 31872533
[TBL] [Abstract][Full Text] [Related]
51. Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients.
Gharbaran R; Goy A; Tanaka T; Park J; Kim C; Hasan N; Vemulapalli S; Sarojini S; Tuluc M; Nalley K; Bhattacharyya P; Pecora A; Suh KS
J Hematol Oncol; 2013 Aug; 6():62. PubMed ID: 23988031
[TBL] [Abstract][Full Text] [Related]
52. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.
Vockerodt M; Wei W; Nagy E; Prouzova Z; Schrader A; Kube D; Rowe M; Woodman CB; Murray PG
J Pathol; 2013 Aug; 230(4):399-409. PubMed ID: 23592216
[TBL] [Abstract][Full Text] [Related]
53. Concurrent gastric MALT and Hodgkin lymphoma: a case report.
Oka K; Nagayama R; Yonekawa N; Nihei T; Sando N; Yatabe Y; Mori N
Int J Surg Pathol; 2012 Apr; 20(2):201-4. PubMed ID: 21813545
[TBL] [Abstract][Full Text] [Related]
54. Classical Hodgkin lymphoma occurring in clusters of nodal marginal zone B-lymphocytes in association with progressive transformation of germinal center. A case report.
Kojima M; Nakamura S; Shimizu K; Tanaka H; Yamane Y; Sugihara S; Masawa N
Pathol Res Pract; 2003; 199(8):547-50. PubMed ID: 14533939
[TBL] [Abstract][Full Text] [Related]
55. Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma.
Hollander P; Ginman B; Molin D; Enblad G; Amini RM; Glimelius I
Immunobiology; 2020 Jan; 225(1):151872. PubMed ID: 31787352
[TBL] [Abstract][Full Text] [Related]
56. HHV8-positive, EBV-positive Hodgkin lymphoma-like large B cell lymphoma: expanding the spectrum of HHV8 and EBV-associated lymphoproliferative disorders.
Sanchez S; Veloza L; Wang L; López M; López-Guillermo A; Marginet M; Martínez A; Balagué O; Campo E
Int J Hematol; 2020 Nov; 112(5):734-740. PubMed ID: 32529584
[TBL] [Abstract][Full Text] [Related]
57. Human herpesvirus 6 positive Reed-Sternberg cells in nodular sclerosis Hodgkin lymphoma.
Siddon A; Lozovatsky L; Mohamed A; Hudnall SD
Br J Haematol; 2012 Sep; 158(5):635-43. PubMed ID: 22757777
[TBL] [Abstract][Full Text] [Related]
58. Composite lymphoma: EBV-positive classic Hodgkin lymphoma and peripheral T-cell lymphoma: a case report.
Gualco G; Chioato L; Van Den Berg A; Weiss LM; Bacchi CE
Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):72-6. PubMed ID: 19115485
[TBL] [Abstract][Full Text] [Related]
59. Pathway-focused gene expression profiles and immunohistochemistry detection identify contrasting association of caspase 3 (CASP3) expression with prognosis in pediatric classical Hodgkin lymphoma.
Vera-Lozada G; Segges P; Stefanoff CG; Barros MHM; Niedobitek G; Hassan R
Hematol Oncol; 2018 Oct; 36(4):663-670. PubMed ID: 29901224
[TBL] [Abstract][Full Text] [Related]
60. Reed-Sternberg-Like Cells in Non-Hodgkin Lymphomas.
Gomez-Gelvez JC; Smith LB
Arch Pathol Lab Med; 2015 Oct; 139(10):1205-10. PubMed ID: 26414463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
